Clinical Hematology Research Career Development Program (K12)

The summary for the Clinical Hematology Research Career Development Program (K12) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Clinical Hematology Research Career Development Program (K12): Purpose: The purpose of this Program is to develop and evaluate multidisciplinary career development programs in non-malignant hematology that will equip new investigators with the knowledge and skills to address complex problems in blood diseases. Through this Program, the NHLBI will support the early career development of clinical researchers who are expected to become independent investigators and assume academic leadership roles in non-malignant clinical hematology. To accomplish this, NHLBI invites institutions with established clinical research infrastructures and expertise in non-malignant clinical hematology to submit applications to establish Clinical Hematology Research Career Development Programs. Programs supported under this RFA should provide comprehensive, multidisciplinary training in research designs and methodologies, standard and potentially future or innovative approaches to the clinical management of patients with non-malignant hem! atologic diseases, and research opportunities in these diseases. Programs should include a core curriculum, didactics, and a short-term research project for each Scholar.
Federal Grant Title: Clinical Hematology Research Career Development Program (K12)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-06-006
Type of Funding: Grant
CFDA Numbers: 93.839
CFDA Descriptions: Blood Diseases and Resources Research
Current Application Deadline: No deadline provided
Original Application Deadline: Feb 14, 2006
Posted Date: Dec 05, 2005
Creation Date: Dec 05, 2005
Archive Date: Mar 16, 2006
Total Program Funding: $2,000,000
Maximum Federal Grant Award: $370,000
Minimum Federal Grant Award:
Expected Number of Awards: 5
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Although foreign institutions are not eligible to apply, foreign collaborators may participate in this program through subcontract(s) with domestic institutions. Applicant institutions must have established clinical research infrastructures and expertise in non-malignant clinical hematology, and strong clinical research faculty with expertise in the related disciplines. . See Section III.3.Other-Specialty Eligibility Criteria.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants
Centers of Excellence for Training in Glycosciences (K12)
Establishment of Research Centers to Investigate the FVIII Immune Response in Patients wit...
Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)
Perinatal Stroke (R01)
Selected Topics in Transfusion Medicine (R01)
Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
Specialized Centers of Clinically Oriented Research (Sccor) in Transfusion Biology and Med...
More Grants from the National Institutes of Health
Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial ...
Investigator-Initiated Clinical Trials Targeting Diseases within the Mission of NIDDK (R01...
NCI National Clinical Trials Network (NCTN)--Network Lead Academic Participating Sites (UG...
Maintaining Immunity After Immunization (U01 - Clinical Trial Optional)
Human Tumor Atlases (HTA) Research Centers (U2C) is not endorsed by, or affiliated with, any government agency. Copyright ©2017